Low Dose Naltrexone (Surprising Inflammation Drug)
6 Dec 2022 · 1 min

0:58
In this concise monologue, the speaker introduces low‑dose naltrexone (LDN), explaining that while standard‑dose naltrexone is used to reverse opioid overdose, a much smaller dose is employed off‑label to modulate the immune system. The talk highlights that LDN is being investigated for a range of conditions—including autoimmune diseases, neurological disorders, and emerging cancer research—and emphasizes that, because it is an off‑label therapy, a qualified practitioner must prescribe it. The core claim is that LDN helps keep the immune system in a balanced state, supporting both healing processes and preventive health.










